Emcure Pharmaceuticals Limited will hold a board meeting on November 3, 2026, to approve the unaudited financial results for both standalone and consolidated entities for the quarter and half-year ended September 30, 2026, according to a regulatory filing with the National Stock Exchange of India and BSE Limited. The trading window for company insiders has been closed since October 1, 2026, and will remain closed until November 5, 2026.</p>